Alert for: fda

fda

India's Glenmark gets US FDA clearance to market skin disorder ...
Forbes - NY,USA
MUMBAI (Thomson Financial) - India's Glenmark Pharmaceuticals Ltd. said its subsidiary Glenmark Generics Ltd. received US FDA approval to market drugs that ...
See all stories on this topic

UPDATE: Glenmark Gets FDA OK For Generic Mometasone Furoate
CNNMoney.com - USA
Glenmark recently received FDA approval also for the 500 milligram, 850 mg and 1 gram tablets of the generic diabetes drug Metformin Hydrochloride. ...
See all stories on this topic

FDA to monitor market performance of drugs
OhMyGov! - Washington,DC,USA
The Food and Drug Administration is developing a tool for monitoring the market performance of drugs and other medical products following FDA approval. ...
See all stories on this topic

Lupin gets tentative approval from FDA
Business Standard - Mumbai,Maharashtra,India
... its marketing application for a generic version of Topiramate tablets in four dosages from the US drug regulator, Food and Drug Administration (FDA). ...
See all stories on this topic

The FDA: Monopoly Medicine
Atlantic Online - USA
Regulatory bodies like the FDA have every incentive to stop the release of new medicine: the government employees involved suffer far more from bad press ...
See all stories on this topic

Ligand: A Blood Bath
Forbes - NY,USA
Ligand investors seem to be giving up on the pharmaceutical company now that the FDA has weighed in, but GlaxoSmithKline won't give up without a fight. ...
See all stories on this topic

Wyeth:FDA Fast Track For Pediatric Pneumococcal Vaccine
CNNMoney.com - USA
Wyeth's (WYE) division, Wyeth Pharmaceuticals, said the Food and Drug Administration granted fast track designation to its investigational 13-valent ...
See all stories on this topic

BOXER BILL ARTICLE IN “FDA WEEK”
Beauty and the Breast - Washington,DC,USA
I just to let you know the following article was posted in the “FDA Week” section of InsideHealthPolicy.com website. Too bad about the “oversight”!!!! Sen. ...
See all stories on this topic

FDA proposes change to physician labeling
United Press International - USA
FDA officials said the proposed changes would provide better information about the effects of medicines used during pregnancy and breast-feeding, ...
See all stories on this topic

Ligand shares fall 34% on FDA report
San Diego Union Tribune - United States
Shares of Ligand Pharmaceuticals plunged 34 percent after federal drug regulators released documents that indicate they do not favor approving the company's ...
See all stories on this topic

Blogs Alert for: fda

FDA notice on Mommy’s Bliss Nipple Cream
By supernovamom
FDA informed consumers NOT to use or purchase Mommy’s Bliss Nipple Cream, marketed by MOM Enterprises, Inc., because the product contains potentially harmful ingredients that may cause respiratory distress or vomiting and diarrhea in ...
- http://supernovamom.wordpress.com

Acomplia — Prefigurement Being from the FDA
By xvrinniskerr
An FDA Sententious trial jury declined freight deliquescence simple Acomplia aforetime – a undoubted fitten clothes therein my judgement. The Mickey Finn had liminal benefits, inflammatory inconsiderable wares ongoing artistic patients ...
Xvrinniskerr's Weblog - http://xvrinniskerr.wordpress.com

Is Grassley barking up the wrong tree at FDA?
By David E. Williams of the Health business blog
Mark Thornton, former medical officer at the FDA’s Office of Oncology Products, takes Senator Charles Grassley (R-IA) to task on the Wall Street Journal’s op-ed page. (See Grassley’s War on Cancer Patients. ...
Health Business Blog - http://www.healthbusinessblog.com

Stupak’s Effort to Arm the FDA with Subpoena Power Over Company ...
By watchdogblog@citizen.org
Bart Stupak, the Michigan Democrat who runs the investigations panel of the House Commerce Committee, has, again, wisely urged the FDA to support Congress’s addition of subpoena power to FDA’s arsenal of tools needed to make our food ...
Watchdog Blog - http://citizen.typepad.com/watchdog_blog/

FDA: Time to pull the plug on a Bloated, Counterproductive Federal ...
By DiscerningBlog
Regulatory bodies like the FDA have every incentive to stop the release of new medicine: the government employees involved suffer far more from bad press for an approved medical technology than they do from the largely unexamined ...
Political Forum - http://www.politicalforum.com